-
Pharma products worth Rs 358 cr sold through Jan Aushadhi stores in this fiscal
expresspharma
November 04, 2020
Likely to surpass sales of Rs 600 crore for the entire fiscal year against Rs 419 crore in 2019-20.
-
Construction Starts on the Medicines Manufacturing Innovation Center
contractpharma
October 28, 2020
CPI has started construction at the Medicines Manufacturing Innovation Center in Renfrewshire, Scotland. The new facility will offer solutions in small molecule and pharmaceutical manufacturing, aiming to accelerate the development and ...
-
AIOCD appeals to PM to utilise their supply chain for COVID-19 vaccine distribution
expresspharma
October 22, 2020
The association has requested the PM to instruct concerned authorities to issue guidelines for use of its channel members to distribute COVID-19 vaccines.
-
Mental Health: A challenge and an opportunity
expresspharma
October 12, 2020
On Mental Health Day, Jayasree K Iyer, Executive Director, Access to Medicine Foundation highlights that mental health should be prioritised as a development issue to solve a major public health challenge and ensure that it remains attractive for ...
-
Indian dose sites untapped M&A opportunity for foreign CMOs: GlobalData
expresspharma
October 09, 2020
Only six US, five UK, and three German CMOs own solid dose manufacturing sites in India.
-
ABPI and EFPIA call for medicines prioritisation in UK/EU trade talks
pharmatimes
September 30, 2020
UK and EU pharmaceutical industry bodies ABPI and EFPIA have joined forces to ask the UK government and the European Commission to prioritise medicines in upcoming trade talks.
-
Government plans a total of 10500 Janaushadhi Kendras by end of March 2024
expresspharma
September 18, 2020
As on 15 September 2020, there were number 6603 stores in the country.
-
LEO Pharma divests four medicines to Cheplapharm for $357m
pharmaceutical-technology
September 01, 2020
Danish medical dermatology company LEO Pharma has divested a portfolio of four non-core medicines to German pharmaceutical firm Cheplapharm for €300m ($357m).
-
Siemens, Perceptive Engineering & PSE Join Medicines Manufacturing Innovation Centre
contractpharma
August 28, 2020
CPI has signed partnership agreements with Siemens plc, Perceptive Engineering LTD and Process Systems Enterprise LTD (PSE), making them a part of the Medicines Manufacturing Innovation Centre collaboration.
-
NPPA issues final guidelines to discontinue making medicines under price control
expresspharma
August 17, 2020
The NPPA website will be uploading the list of applications filed by pharma companies and approved by the competent authority for discontinuation.